Flashcards · Module 8
💊 Polypharmacy & Deprescribing
4 of 4 cards published · read by the site’s author on 15 November 2026
What is a "Prescribing Cascade"? (3 Classic Examples)
Needs clinical review
The Concept:
A side effect of Drug A is mistaken for a new disease, so Drug B is prescribed to treat it — creating more side effects, more drugs, more harm.
3 Classic Cascades Every Student Must Know:
Cascade 1: The Ankle Swelling Trap
Amlodipine → lower-extremity edema → treated with a loop diuretic →
Loop diuretic prescribed → electrolyte abnormalities, urinary incontinence, fall-related injuries
FIX: Discontinue or reduce CCB dose, and use an alternative antihypertensiveCascade 2: The Dementia Double-Cross
Cholinesterase inhibitor (Donepezil) → new-onset urinary incontinence →
Anticholinergic (Oxybutynin) prescribed for the incontinence →
Delirium and cognitive impairment
FIX: Stop Oxybutynin, use Mirabegron as a non-antimuscarinic alternativeCascade 3: The Blood Pressure Spiral
NSAID (Ibuprofen) → raises blood pressure →
Antihypertensive started →
NSAID also causes renal failure and GI bleeding
FIX: Stop the oral NSAID; consider topical NSAIDs or acetaminophenSources checked (8) · 14 November 2026
- Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: A population-based cohort study. (2024)
- Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics. (2019)
- A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. (2005)
- Risk of delirium associated with antimuscarinics in older adults: A case-time-control study. (2022)
- Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms. (2020)
- Prescribing Cascade as a Therapeutic Error: A Danger for Geriatric Patients with Multimorbidity (2026)
- Use of deprescribing to reduce polypharmacy and potentially inappropriate medications in geriatric patients in a tertiary care hospital. (2026)
- Osteoarthritis Therapeutics: From Microenvironment Understanding to Regenerative Intervention-Current Advances and Future Perspectives (2026)
Note: The prescribing cascade concept was originally described by Rochon and Gurwitz. (Impact of Traditional Korean Medicine on Reducing Polypharmacy and Potentially Inappropriate Medications in Elderly Stroke Patients: A Retrospective Cohort Study. (2026))
Note: Oxybutynin is also reported to cause cognitive impairment. (Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms. (2020))
The Beers Criteria: Top 5 Drugs to STOP in Older Adults
Needs clinical review
The 5 Most Dangerous Drug Classes:
| Drug | Why It's Dangerous | Safer Alternative |
|---|---|---|
| 1. Diphenhydramine (Benadryl) | Severe anticholinergic → delirium, falls, urinary retention | Second-generation antihistamines (e.g. Cetirizine) |
| 2. Benzodiazepines / Z-drugs (Zolpidem, Lorazepam) | Cognitive impairment, delirium, falls, fractures | Cognitive behavioral therapy for insomnia (CBT-I) |
| 3. Glyburide (Glibenclamide) | Prolonged hypoglycemia in older adults | Metformin (first-line), DPP-4 inhibitors |
| 4. Amitriptyline (TCA) | Strong anticholinergic activity, cognitive decline, delirium, and falls | SSRIs (e.g. Sertraline) or SNRIs (e.g. Duloxetine) |
| 5. Chronic oral NSAIDs | GI bleeding, renal failure, worsening heart failure | Topical NSAIDs, Acetaminophen |
Memory Aid — "Bad BANG Drugs":
Benzodiazepines
Anticholinergics (Diphenhydramine, Oxybutynin, Amitriptyline)
NSAIDs (chronic oral)
Glyburide (Glibenclamide)
Sources checked (9) · 14 November 2026
- American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. (2023)
- Use of deprescribing to reduce polypharmacy and potentially inappropriate medications in geriatric patients in a tertiary care hospital. (2026)
- Management of Itch in the Elderly: A Review. (2019)
- Developing a Warning Model of Potentially Inappropriate Medications in Older Chinese Outpatients in Tertiary Hospitals: A Machine-Learning Study. (2023)
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016)
- Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy. (2019)
- Integrated approaches to geriatric mental disorders: pathophysiology, interventions, and precision medicine horizons (2026)
- Osteoarthritis Therapeutics: From Microenvironment Understanding to Regenerative Intervention-Current Advances and Future Perspectives (2026)
- Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep. (2017)
Note: Loratadine has the most anticholinergic effects of all second-generation antihistamines and should be avoided in the elderly. (Management of Itch in the Elderly: A Review. (2019))
Note: The updated Beers Criteria flags sulfonylureas like glimepiride in addition to glyburide due to their high risk of prolonged hypoglycemia in older adults. (Use of deprescribing to reduce polypharmacy and potentially inappropriate medications in geriatric patients in a tertiary care hospital. (2026))
The "Triple Whammy" that Destroys Kidneys
Needs clinical review
The Deadly Combination:
NSAID + ACE inhibitor/ARB + Diuretic = Acute Kidney Injury
Why (in simple hemodynamics):
KIDNEY BLOOD FLOW:
Afferent Arteriole → [GLOMERULUS] → Efferent Arteriole
(Blood IN) (Filtration) (Blood OUT)
NSAID blocks prostaglandins → Afferent arteriole CONSTRICTS (less blood IN)
ACEi/ARB blocks angiotensin II → Efferent arteriole DILATES (pressure OUT drops)
Diuretic → DEPLETES blood volume
Result: Filtration pressure collapses → glomerular filtration drastically declines → Acute Kidney InjuryClinical Scenario:
An older patient on Ramipril (ACEi) + Furosemide (diuretic) gets started on Ibuprofen for knee pain → within days, creatinine doubles, potassium rises → emergency admission for AKI.
Sources checked (1) · 14 November 2026
Anticholinergic Burden: When Medications Add Up to Dementia
Needs clinical review
The Concept:
Each drug has an Anticholinergic Cognitive Burden (ACB) score. The scores add up across all medications:
The Danger Score:
Definite Anticholinergic Use (ACB scale) = greater cognitive decline (0.33 MMSE points) + higher mortality (OR 1.68)
Commonly Overlooked High-Scoring Drugs (3 Points Each):
💊 Diphenhydramine (OTC "Benadryl" / sleep aids)
💊 Oxybutynin (bladder medication)
💊 Amitriptyline (antidepressant / pain)
💊 Paroxetine (ACB score = 3)
💊 Promethazine (anti-nausea)
💊 Hydroxyzine (anti-anxiety / itch)
A Patient Example:
Mrs. Jones takes:
Oxybutynin (ACB = 3) + Paroxetine (ACB = 3) + Mirtazapine (ACB = 1) = Total ACB = 7
→ She has an increased cumulative risk of cognitive impairment and mortality
→ Action: Switch Oxybutynin → Mirabegron (guideline-recommended alternative to antimuscarinics);
Paroxetine (ACB = 3) and Mirtazapine (ACB = 1) still add 4 pointsSources checked (6) · 14 November 2026
- Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. (2011)
- High Anticholinergic Burden of Patients Hospitalized for Hip Fracture Reveals a Target for Deprescribing (2025)
- A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales. (2021)
- Deriving the anticholinergic medication index for delirium and falls in older people: development and external validation of a risk prediction model (2026)
- Navigating the challenges of overactive bladder management in women (2026)
- Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients. (2024)
Note: Oxybutynin and paroxetine each score 3 points on the ACB scale. (A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales. (2021))
Note: In the landmark MRC CFAS cohort by Fox and colleagues, definite anticholinergic use was associated with greater cognitive decline (MMSE decline 0.33 points) and higher mortality (OR 1.68). (Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. (2011))